MENU

Altamira Therapeutics (CYTO) Ownership - Who owns Altamira Therapeutics?

Industry: @Biotechnology

Profile

Industry
Biotechnology
Address
2 Church Street
Phone
+1 441 295-5950
Employees
18
Web
https://www.altamiratherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.1M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.32
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CYTO
Capitalization
3.1M
P/E Ratio
N/A
Risk (Beta)
2.32
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
N/A
P/B Ratio
0.40
Cash Flow
N/A
Earnings
-7.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
1.38
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-6.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-55.29
Shares Held By Institutions
6.93K
Shares Outstanding - Current
2.67M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-68.966
View a ticker or compare two or three
CYTO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Church Street
Phone
+1 441 295-5950
Employees
18
Web
https://www.altamiratherapeutics.com